Olema Pharmaceuticals inc (OLMA)
12.19
-0.03
(-0.25%)
USD |
NASDAQ |
Sep 27, 16:00
12.19
0.00 (0.00%)
After-Hours: 20:00
Olema Pharmaceuticals Cash from Financing (Quarterly): 15.60M for June 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 15.60M |
| March 31, 2024 | 8.821M |
| December 31, 2023 | 0.523M |
| September 30, 2023 | 130.63M |
| June 30, 2023 | 2.043M |
| March 31, 2023 | 0.22M |
| December 31, 2022 | 0.273M |
| September 30, 2022 | 0.106M |
| June 30, 2022 | 0.064M |
| Date | Value |
|---|---|
| March 31, 2022 | 0.033M |
| December 31, 2021 | 0.818M |
| September 30, 2021 | 0.057M |
| June 30, 2021 | 0.516M |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 219.79M |
| September 30, 2020 | 84.87M |
| June 30, 2020 | 23.75M |
| March 31, 2020 | 29.99M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
Mar 2021
219.79M
Maximum
Dec 2020
28.78M
Average
0.6705M
Median
Cash from Financing (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -0.492M |
| Palatin Technologies Inc | 9.136M |
| iBio Inc | 12.99M |
| Theriva Biologics Inc | 1.773M |
| Oragenics Inc | 0.8212M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -27.56M |
| Cash from Investing (Quarterly) | -4.878M |
| Free Cash Flow | -92.43M |
| Free Cash Flow Per Share (Quarterly) | -0.4897 |
| Free Cash Flow Yield | -14.32% |